British drugmaker GlaxoSmithKline (GSK) has submitted a marketing authorisation application (MAA) to the European Medicines Agency (EMA) for its cervical cancer vaccine, Cervarix [Human papillomavirus bivalent (types 16 and 18) vaccine, ...
Tags: Cervarix, Schedule Application
British drugmaker AstraZeneca and US biotechnology company FibroGen have formed a strategic partnership to develop and commercialize FG-4592 to treat anemia in patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD). ...
Tags: Anemia Drug, Astrazeneca
Swiss drugmaker Novartis has announced that once-daily dual bronchodilator, Ultibro Breezhaler (QVA149), has achieved positive CHMP opinion for the treatment of chronic obstructive pulmonary disease (COPD). Ultibro Breezhaler was ...
Karo Bio, a drugmaker for large medical needs, has selected Reaxys and Reaxys Medicinal Chemistry solutions, which will enable the company's chemists to access chemistry information, while help achieve their research and development ...
Tags: Medicinal Chemistry, Medicine
India-based drugmaker Sun Pharmaceutical Industries is said to be in advanced negotiations to acquire Sweden-based Meda in a deal valued at $5-$6bn. Sources close to the deal were quoted by Reuters as saying that the acquisition will ...
Drugmaker in Bangladesh Square Pharmaceuticals has contracted Spain-based Telstar to build two new pharmaceutical plants, an oral solids facility and parenteral drugs making facility for the company. The 32,000m2 solid dose facility will ...
Tags: Square Pharmaceuticals, pharmaceutical plants, oral solids facility
Teva Pharmaceutical Industries has decided not to launch atorvastatin, a generic version of Pfizer's Lipitor. The decision will help Ranbaxy Laboratories and Dr Reddy's Laboratories gain larger sales of the medicine in the US, the ...